A year of winners (and losers) post-'Alpha'
A year of winners (and losers) post-'Alpha'

It's less than one week before CNBC and Institutional Investor's fourth annual Delivering Alpha Conference on July 16, and a combination of choppy markets and mixed investment successes promise to make the event colorful.

According to HFR data, hedge funds picked up some steam in June, rising 1.3 percent, which is just slightly lower than the broader market, with the S&P 500 (INDEX:^GSPC - News) gaining 1.9 percent in the month. However, the year-to-date numbers show hedge funds still have a ways to go to catch up to markets that are continually hitting new highs-the average hedge fund is up 3.2 percent, while the S&P has gained 6.1 percent through the end of June.

Of course, there are some exceptions-and some of 2014's biggest winners are slated to share their next big ideas at this year's Delivering Alpha Conference.

One is Larry Robbins , whose Glenview Fund is up more than 11 percent year to date. Joining Robbins are some of Wall Street's elite, most of whom are known for their sharp views of the markets, including Leon Cooperman , John Paulson , Carl Icahn , Mary Callahan Erdoes, Michael Novogratz and Ken Griffin .

Judging from last year, there should be plenty of investible advice at this year's event. Here's the rundown of how some of the key players fared in the nearly 12 months since last year's gathering

(All stock gains/losses have been calculated from July 17, 2013-Monday unless otherwise noted.)

Robbins, the Glenview Capital Management CEO, had a standout year in 2013 and turned out to be the top stock picker of DA 2014. Robbins, who disclosed he had a $2 billion hospital portfolio, looked at the opportunities in Obamacare as two-sided, winners and losers, and offered up three long recommendations which have all delivered double-digit gains to date:

Read More A look at 5 hedge fund stars of the future

Walgreen (NYSE:WAG - News). Robbins believed that to the extent there's more customers of health care, more insurance coverage and therefore more doctors' visits, that some of this uptick in health care will be taken care of locally at walk-in clinics within Walgreen. His pharmaceutical services space pick has surged 47 percent since last year.

McKesson (NYSE:MCK - News), which Robbins has had a stake in since 2004, was his best performing stock pick from last year, gaining 59 percent.

Thermo Fisher Scientific (NYSE:TMO - News), which was his No. 1 holding at the time, is up 35 percent.

Nelson Peltz, of Trian Fund Management, also scored with an investment in Dupont (NYSE:DD - News) that he reluctantly disclosed at Delivering Alpha last year; the chemical company is up 20 percent to date. The activist investor's larger theme of the day was around PepsiCo (NYSE:PEP - News) and the snack maker, Mondelez (NASDAQ:MDLZ - News), which he wanted the former to buy. While that deal never happened, Mondelez stock has jumped 28 percent, while Pepsico is up a respectable 7 percent.